Canada's CDPQ to Invest More Than $10 Billion in UK, FT Says
CDPQ, Canada's second-largest pension fund managing C$473 billion ($344 billion), could raise its allocation to UK assets by 50% in that period, the FT reported Sunday, citing an interview with the fund's Chief Executive Officer Charles Emond.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Mountain Valley MD Holdings Announces Changes to Board of Directors
TORONTO, July 24, 2025--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to announce the appointment of David Batchelor to its board of directors. David Batchelor is a seasoned organizational strategist and business transformation expert with more than 25 years of experience advising executive teams and boards on performance improvement, financial discipline, and enterprise value creation. His work spans a wide range of industries—including finance, healthcare, consumer goods, technology, and manufacturing—and includes engagements with global leaders such as Cisco, Coca-Cola, IBM, Merck, Bayer, and Johnson & Johnson. David brings a unique blend of systems thinking, operational insight, and financial acumen to drive results at the intersection of strategy and execution. With a strong foundation in governance and performance science, David is particularly skilled in helping organizations optimize capital allocation, align leadership structures, and implement high-leverage interventions that improve profitability and accountability. His academic background includes a Master's degree in Distributed Learning (Organizational Leadership), undergraduate studies in Management Science, and CMA coursework. As a published author and educator, he has held faculty and program leadership roles at the Schulich Executive Education Centre (York University) and Royal Roads University. David is known for his practical, people-centric approach to driving sustainable business success. "We are very excited to have David Batchelor join our board of directors at this important time in MVMD's development," stated Dennis Hancock, President and CEO of MVMD. "David brings a proven track record in business growth, governance, and financial management that aligns perfectly with our priorities for growth, commercialization, and disciplined capital deployment." The Company also announces the resignations of Kevin Puloski and Nancy Richardson as directors of the Company. Mr. Hancock continued: "As we continue to advance our strategic priorities, including commercialization and capital market initiatives, we're making important enhancements to the composition of our Board. We extend our thanks to the outgoing directors for their contributions and wish them well. The newly appointed director brings relevant perspectives and complementary strengths, reinforcing our commitment to disciplined execution and long-term value creation." ABOUT MOUNTAIN VALLEY MD HOLDINGS Valley MD is building a world-class organization centered around the implementation, licensing and reselling of key technologies and formulations: patented Quicksome™ oral formulation and delivery technologies, patented Quicksol™ solubility formulation technology licensed product reseller of Agrarius™, a novel agricultural plant signaling technology Consistent with its vision towards "More Life", MVMD applies its owned and licensed technologies to its work for advanced delivery of molecules for human and husbandry animal applications, including the development of products for pain management, weight loss, energy, focus, sleep, anxiety, and more. Additionally, MVMD's work with Agrarius is focused on generating a positive impact on crop yields and reducing fertilizer usage. MVMD's patented Quicksome™ technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into highly efficient product formats. The result is a new generation of product formulations that could be capable of delivering nutraceutical and drug molecules into the body faster, with greater impact, efficiency and accuracy. MVMD's patented Quicksol™ technology covers all highly solubilized macrocyclic lactones that could be effectively applied in multiple viral applications that could positively impact human and animal health globally. MVMD's licensed Agrarius™ agricultural plant signaling technology is designed to be applied to crops to naturally increase yields, reduce fertilizer usage, and increase general resilience to pests and climate change. For more Company information and contact details, visit SOURCE: Mountain Valley MD Holdings Inc. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION Certain statements contained in this news release may constitute forward-looking information. Forward-looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The Company's actual results could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which the Company operates, prevailing economic conditions, and other factors, many of which are beyond the control of the Company. The Company believes that the expectations reflected in the forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward-looking information contained in this news release represents the Company's expectations as of the date hereof and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation. Neither the CSE nor OTC has reviewed or approved the contents of this press release. View source version on Contacts For further information:Dennis HancockPresident and Chief Executive OfficerMountain Valley MD Holdings Relations @ 647-725-9755Email: info@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
New York Times
an hour ago
- New York Times
Why Does Anyone Think Trump Will Uphold His End of a Bargain With Columbia?
In 1672, Charles II unilaterally suspended repayment of 1.2 million pounds to London's private bankers. Having run up this debt, and unable to finance a flotilla of ships to fight the Dutch, Charles became neither the first nor the last absolute monarch to break his word. James II, his sibling successor, went further, claiming royal prerogative to bypass laws and purge Protestant judges, generals and functionaries. The solemn oaths he made at his coronation, to respect Parliament and the Church of England, wound up being worth not very much. James ruled for less than four years, deserting after the Glorious Revolution began the era of parliamentary supremacy. Parliament would approve only those loans it would be willing to pay back with taxes, enabling deals with creditors now willing to lend. By restraining the monarch's power, it enabled the crown to make deals it couldn't otherwise get. In economic history, we teach the 1688 creation of parliamentary supremacy as a solution to what economists call 'commitment problems.' In the absence of a third party sufficiently strong to make sure all sides stick to their promises, the powerful can renege on the powerless. The powerless, seeing this, wisely choose to not contract with the powerful. Absolutist rulers are victims of their own lack of restraints; a sovereign who is too powerful cannot get inexpensive credit, because nothing stops the ruler from defaulting on any bond. President Trump, by smashing checks on his authority, has wound up undermining his own ability to make credible deals, including the one just reached with Columbia University, where I teach. The entities that have been striking deals with Mr. Trump, my own employer included, have not learned the lessons of the Glorious Revolution. Trade negotiators from longtime partner countries, government contractors, law firms, federal employees, permanent residents, the Federal Reserve chair Jerome Powell, even the Transportation Security Administration labor union are all experiencing contractual vertigo, finding out that the administration will not honor previous agreements. The first Trump administration renegotiated the North American Free Trade Agreement to get the United States-Mexico-Canada Agreement, but Mr. Trump has imposed tariffs on Mexico and Canada in violation of even that agreement. Parties thinking they can wheedle their way into a bargain with a capricious administration are bringing intuitions from the world of private deals, backstopped by the rule of law, into the very different realm of political bargains with absolutism-adjacent executive branches. I understand the desire for a deal. My colleagues and I have eagerly clicked on every news story hinting that Columbia's leaders might have secured the hundreds of millions of dollars the Trump administration has frozen or cut. Our community has borne devastating cuts, with researchers and administrative staff members laid off and participants in medical research losing access to treatment midcourse. On top of that, Immigration and Customs Enforcement has detained a number of our students, and there have been endless leaks, doxxing attacks, campus lockdowns and computer hacks. All of this manifests as a never-ending stream of anxiety — financial, physical, moral — that narrows whatever intellectual horizons the research university is supposed to foster. Want all of The Times? Subscribe.
Yahoo
an hour ago
- Yahoo
Harmony Gold (HMY) Stock Sinks As Market Gains: What You Should Know
Harmony Gold (HMY) closed at $14.83 in the latest trading session, marking a -1.33% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.78%. Elsewhere, the Dow saw an upswing of 1.14%, while the tech-heavy Nasdaq appreciated by 0.61%. Shares of the gold miner have appreciated by 6.67% over the course of the past month, outperforming the Basic Materials sector's gain of 6.63%, and the S&P 500's gain of 5.88%. The investment community will be closely monitoring the performance of Harmony Gold in its forthcoming earnings report. In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $2.85 per share and a revenue of $0 million, indicating changes of +190.82% and 0%, respectively, from the former year. It is also important to note the recent changes to analyst estimates for Harmony Gold. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability. Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.71% upward. Harmony Gold presently features a Zacks Rank of #1 (Strong Buy). Valuation is also important, so investors should note that Harmony Gold has a Forward P/E ratio of 5.27 right now. For comparison, its industry has an average Forward P/E of 12.14, which means Harmony Gold is trading at a discount to the group. It is also worth noting that HMY currently has a PEG ratio of 0.09. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. By the end of yesterday's trading, the Mining - Gold industry had an average PEG ratio of 0.57. The Mining - Gold industry is part of the Basic Materials sector. This industry, currently bearing a Zacks Industry Rank of 12, finds itself in the top 5% echelons of all 250+ industries. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Keep in mind to rely on to watch all these stock-impacting metrics, and more, in the succeeding trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Harmony Gold Mining Company Limited (HMY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
